Please login to the form below
Portugal
This page shows the latest Portugal news and features for those working in and with pharma, biotech and healthcare.
Shire files dry eye drug lifitegrast in Europe
Rather than submitting the marketing application to the EMA, Shire has filed lifitegrast using the decentralised procedure (DCP) to Denmark, Norway, Sweden, Finland, the UK, Germany, the Netherlands, France, Italy, Portugal,
Latest news
-
Most of the EU would like to host the EMA
Milan (Italy). Porto (Portugal). Sofia (Bulgaria). Stockholm (Sweden). Malta (Malta). Vienna (Austria).
-
Bial launches video campaign for World Parkinson’s Day
Portugal-based pharma company Bial has launched a video campaign, ‘Me At My Best’, to raise awareness of Parkinson’s disease.
-
Type 2 diabetes can be reversed in just four months, say researchers
had diabetes in 2014 – with the highest levels in Greece, Portugal and France – and that the disease cost around 100bn in 2013.
-
Value for money healthcare - Macedonia and Estonia lead
Estonia and the Czech Republic provide very good healthcare in relation to the cost, with Finland and Portugal also rising up the rankings on this measure.
-
Access to orphan drugs for rare cancers in EU28
Countries like Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, the Netherlands, Portugal, Romania, Slovenia, Spain, Sweden and the United Kingdom have nationalised regulations and well-defined
More from news
Approximately 0 fully matching, plus 84 partially matching documents found.
Latest Intelligence
-
The sound of silence puts the squeeze on generics and biosimilars
landscape. “Where we see the challenge is where government-mandated price cuts are imposed without discussion or compensation over volume and we have seen that in recent years in Portugal, France
-
Market access improvements in Turkey
Italy, Portugal and Spain plus the country of origin).
-
Challenging perceptions
Before relocating for his new role in Switzerland, he spent nearly five years as a business unit director for neuroscience for Spain and Portugal.
-
Case study: Cancer cookbook
Results. To date, more than 20, 000 copies have been distributed across the UK, Portugal, Germany, Austria, Switzerland and Italy.
-
Case study: Cancer cookbook
Results. To date, more than 20, 000 copies have been distributed across the UK, Portugal, Germany, Austria, Switzerland and Italy.
More from intelligence
Approximately 2 fully matching, plus 12 partially matching documents found.
Latest appointments
-
ClinTec appoints regional manager for Spain and Portugal
ClinTec appoints regional manager for Spain and Portugal. Carlos Palacios joins the contract research organisation. ... Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager
-
Former Roche CEO joins BIAL board
Portugal-based pharma company BIAL has appointed former Roche CEO Franz Humer as a non-executive member of its board.
-
IMI appoints new chair of scientific committee
IMI appoints new chair of scientific committee. Portugal’ s Maria Beatriz da Silva Lima to join EC’ s collaborative research group. ... Prof da Silva Lima (pictured) of the University of Lisbon in Portugal will lead a 12-strogn committee, which
-
Tonio Borg nominated to replace John Dalli as EC Health Commissioner
by a representative from Malta until 2014 under the presidency of Portugal's José Manuel Barroso.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Spotlight on Events
We are working in globally diverse destinations, such as Hong Kong, Singapore, Korea, Australia, Germany, Portugal and Spain.
-
Nagore Fernandez announced as Head of Clinical Services – Europe
Nagore Fernandez announced as Head of Clinical Services – Europe. With Clinical services across a number of European countries (including the EU5, Turkey and Portugal) and plans for further expansion, Ashfield is
-
Enablers of drug innovation could lie in the numbers
Between 1997 and 2011, the twelve largest drug developers spent a massive $802 billion on R&, D2, the equivalent of bailing out Greece, Ireland, Portugal and Spain during the Euro Crisis
-
Nagore Fernandez announced as Head of Clinical Services – Europe
Nagore Fernandez announced as Head of Clinical Services – Europe. With Clinical services across a number of European countries (including the EU5, Turkey and Portugal) and plans for further expansion, Ashfield is
-
Spotlight on Events
We are working in globally diverse destinations, such as Hong Kong, Singapore, Korea, Australia, Germany, Portugal and Spain.
More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.
Featured jobs
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Senior Account Manager
-
Competitive salary commensurate with experience
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- MaxCyte gets green light for solid tumour cell therapy
- Brexit rebels win vote on European Medicines Agency alignment
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
- Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
- Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
- AstraZeneca joins Merck in Brexit stockpiling effort
PMHub
infill healthcare communication
infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
